BRCA1/2 testing in hereditary breast and ovarian cancer families II: Impact on relationships

被引:28
|
作者
McInerney-Leo, A
Biesecker, BB
Hadley, DW
Kase, RG
Giambarresi, TR
Johnson, E
Lerman, C
Struewing, JP
机构
[1] NHGRI, Med Genet Branch, Bethesda, MD 20892 USA
[2] NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA
[3] Westat Res, Rockville, MD USA
[4] Johns Hopkins Biostat Ctr, Baltimore, MD USA
[5] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
[6] NCI, Lab Populat Genet, Bethesda, MD 20892 USA
关键词
family cohesion; conflict; expressiveness; genetic counseling; cancer risk testing;
D O I
10.1002/ajmg.a.30566
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Members of hereditary breast and ovarian cancer (HBOC) families often express concern during genetic counseling about the impact of BRCA1/2 testing on close relatives. Yet whether there are likely to be adverse effects of either the decision to undergo genetic testing or the results of testing on family relationships is unknown. One purpose of this study was to assess the impact on close family relationships. Within a randomized trial of breast cancer genetic counseling methods, members of 13 HBOC families were offered BRCA1/2 testing for a known family mutation. The Family Relationship Index (FRI) of the Family Environment Scale (FES) was used to measure perceived family cohesion, conflict, and expressiveness at baseline and again 6-9 months following the receipt of test results, or at the equivalent time for those who declined testing. Participants (n = 212) completed baseline and follow-up questionnaires. Comparisons were made between testers and non-testers as well as between those who tested positive and negative for the family mutation. One hundred eighty-one participants elected to undergo genetic testing (85%) and 47 (26%) were identified to have a mutation. After adjusting for baseline family relationship scores, counseling intervention, gender and marital status, non-testers reported a greater increase in expressiveness (P = 0.006) and cohesion (P = 0.04) than testers. Individuals who tested positive reported a decrease in expressiveness (P = 0.07), although as a trend. Regardless of test decision or test result, those who were randomized to a client-centered counseling intervention reported a decrease in conflict (P = 0.006). Overall, study results suggest that undergoing genetic testing and learning ones BRCA1/2 status may affect family relationships. Those individuals who declined testing reported feeling closer to family members and more encouraged to express emotions to other family members demonstrating potential benefit from the offer of testing. Since those who tested positive reported feeling less encouraged to express their emotions within the family, we recommend helping clients to identify others with whom they feel comfortable sharing their thoughts and feelings about their positive gene status and increased cancer risk. Published 2005 Wiley-Liss, Inc.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 50 条
  • [31] The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry
    Peixoto, A.
    Santos, C.
    Pinto, P.
    Pinheiro, M.
    Rocha, P.
    Pinto, C.
    Bizarro, S.
    Veiga, I.
    Principe, A. S.
    Maia, S.
    Castro, F.
    Couto, R.
    Gouveia, A.
    Teixeira, M. R.
    CLINICAL GENETICS, 2015, 88 (01) : 41 - 48
  • [32] Relative frequency of BRCA2 versus BRCA1 mutations in Spanish families with hereditary breast/ovarian cancer.
    Polo, E
    Andres, R
    Mayordomo, J
    Godino, J
    Lara, R
    Lambea, J
    Caldes, T
    De La Hoya, M
    Perez-Segura, P
    Tres, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 881S - 881S
  • [33] BRCA1 and BRCA2 in hereditary breast cancer
    Scully, R
    Puget, N
    BIOCHIMIE, 2002, 84 (01) : 95 - 102
  • [34] BRCA1 and BRCA2 genes:: Role in hereditary breast and ovarian cancer in Italy
    Santarosa, M
    Dolcetti, R
    Magri, MD
    Crivellari, D
    Tibiletti, MG
    Gallo, A
    Tumolo, S
    Della Puppa, L
    Furlan, D
    Boiocchi, M
    Viel, A
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (01) : 5 - 9
  • [35] Hereditary breast and ovarian cancer in Asia:: Genetic epidemiology of BRCA1 and BRCA2
    Liede, A
    Narod, SA
    HUMAN MUTATION, 2002, 20 (06) : 413 - 424
  • [36] Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2
    Hoang, Lien N.
    Gilks, Blake C.
    ADVANCES IN ANATOMIC PATHOLOGY, 2018, 25 (02) : 85 - 95
  • [37] TESTING FOR BRCA1 IN HEREDITARY BREAST-CANCER - REPLY
    TRICHE, TJ
    DOLGINOW, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (11): : 846 - 846
  • [38] BRCA1 and BRCA2 sequence variants in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Benais-Pont, Gaelle
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Maillet, Philippe
    CANCER RESEARCH, 2010, 70
  • [39] BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer
    Schubert, EL
    Mefford, HC
    Dann, JL
    Argonza, RH
    Hull, J
    King, MC
    GENETIC TESTING, 1997, 1 (01): : 41 - 46
  • [40] Germline Mutations of BRCA1 and BRCA2 in Korean Breast and/or Ovarian Cancer Families
    Kang, Hio Chung
    Kim, Il-Jin
    Park, Jae-Hyun
    Kwon, Hyuk-Jun
    Won, Yong-Jin
    Heo, Seung Chul
    Lee, Sang-Yon
    Kim, Kyung-Hee
    Shin, Yong
    Noh, Dong Young
    Yang, Dae-Hyun
    Choe, Kuk Jin
    Lee, Bong Hwa
    Kang, Soon Beom
    Park, Jae-Gahb
    HUMAN MUTATION, 2002, 20 (03) : 235